Gland Pharma Ltd - 543245 - Outcome Of The Board Meeting
The Board of Directors at its meeting held on May 18, 2023 has inter-alia approved the Audited financial results of the Company for the quarter and financial year ended March 31, 2023. The 45th Annual General Meeting of the members of the Company will be held through video conferencing (VC)/ other audio-visual means (OAVM) on Thursday, August 31, 2023. Gland Pharma Ltd - 543245 - Audited Financial Results For The Quarter And Year Ended March 31, 2023
Audited Financial Results for the quarter and year ended March 31, 2023 Gland Pharma Ltd - 543245 - Board Meeting Outcome for Outcome Of The Board Meeting
The Board of Directors at its meeting held on May 18, 2023 has inter-alia approved the Audited financial results of the Company for the quarter and financial year ended March 31, 2023. The 45th Annual General Meeting of the members of the Company will be held through video conferencing (VC)/ other audio-visual means (OAVM) on Thursday, August 31, 2023. Gland Pharma Ltd - 543245 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended 31st March 2023 Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Conference Call - Q4FY23 Gland Pharma Ltd - 543245 - Board Meeting Intimation for Board Meeting Intimation For The Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2023.
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2023 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2023. Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
Update on Acquisition
China's Fosun drops plan to sell stake in drugmaker Gland Pharma: Report
Fosun Pharma holds a 57.86% stake in the Indian company Gland Pharma Ltd - 543245 - Reply To The Clarification Sought By BSE
Reply to the Clarification sought by BSE